Corrigendum to "High expression of DLL3 is associated with a poor prognosis and immune infiltration in invasive breast cancer patients" [Translational Oncology 14 (2021) 101080]

Transl Oncol. 2021 Aug;14(8):101120. doi: 10.1016/j.tranon.2021.101120. Epub 2021 May 20.
No abstract available

Publication types

  • Published Erratum